Analysis of the in vitro activity of different compounds in their inhibition ability against SARS-CoV-2 in human Caco2 cells.
In a 5641-compound library, 19 compounds were considered confirmed actives with IC50"

This study is not published and not peer reviewed yet. It cannot be used to inform clinical practice, or referenced by the media as validated information.
This study shows the in vitro potential of CPC in the inhibition of SARS-CoV-2 in human cells. It should be confirmed with further in vitro and clinical trials in this virus.